Status:
RECRUITING
Tricuspid RegUrgitaTion Hamburg Cohort
Lead Sponsor:
Universitätsklinikum Hamburg-Eppendorf
Conditions:
Tricuspid Regurgitation
Eligibility:
All Genders
18+ years
Brief Summary
Tricuspid regurgitation (TR) is frequent and has been directly related to high mortality rates. The pathophysiology of TR is mainly functional as it occurs predominantly in the context of left-sided h...
Eligibility Criteria
Inclusion
- Ability to provide written informed consent in accordance with Good Epidemiological Practice and local legislation.
- Individuals over the age of 18 years.
- Patients with clinically relevant tricuspid regurgitation (≥ severe TR, at least Grade III of V)
Exclusion
- Insufficient knowledge of the German language, to understand study documents and interview without translation
- Physical or psychological incapability to cooperate in the investigation
Key Trial Info
Start Date :
June 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2030
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT04755842
Start Date
June 1 2020
End Date
December 31 2030
Last Update
May 31 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Heart and Vascular Center Hamburg
Hamburg, Germany, 20246